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A novel Schiff base (E)-N-(pyridine-2-yl)thiophen-2-ylmethylene)hydrazine carbothioamide (L), has been synthesised 
by the condensation of thiophen-2-carbaldehyde and 4-(pyridin-2-yl)-thiosemicarbazide, using solvent free microwave 
synthesis. The Co(II), Ni(II), Cu(II) and Zn(II) complexes of the Schiff base are also prepared. They are characterised by 
elemental analysis, EI-mass spectrum, 1H &13C-NMR spectrum, FTIR, UV-vis spectra, magnetic, EPR spectra and thermal 
analysis. The “SNSN” donor ligand binds the metal ion in tetradentate mode through thiophenyl and thioenolic sulphur 
atoms and imino and pyridine nitrogen atoms. The electronic spectra along with magnetic measurements demonstrate 
tetrahedral geometry for Co(II), Ni(II) and Zn(II) complexes, and square planar geometry for Cu(II) complex. All the 
complexes are found to be thermally stable from thermogravimetric studies. The complexes show enhanced antibacterial 
activity than the ligand against various bacterial strains. The BSA binding activity of the complexes shows that the affinity 
for binding is greater towards copper complex. The cytotoxicity of the ligand and its complexes are tested on HT29 colon 
cancer cells using MTT assay. 
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Bioinorganic complexes play vibrant role in the 
human physiological system. Among various type of 
metal complexes, Schiff bases and their corresponding 
metal complexes have been studied with great 
enthusiasm by inorganic chemists. Even though 
innumerable number of papers have been reported on 
Schiff base complexes, for decades, the researchers 
are still fascinated by the immense diversity of their 
applications. The facile synthetic methods, easy 
availability and electronic properties are the 
motivation for the extensive research of Schiff base 
complexes. 
The nitrogen, sulphur and oxygen donor atoms 
available in Schiff bases can make this class of 
compounds very efficient catalysts in different organic 
reactions like oxidation, reduction, bond formation, 
hydrolysis etc1-4. By thoughtfully inserting electron 
withdrawing or donating substituent, the electronic 
properties of the Schiff bases can be fine-tuned 
according to our need. Because of this interesting 
option, they find very attractive and diverse 
applications like antimicrobial agents5, sensor 
materials6, pharmacological and electrochemical 
agents7. Due to the existence of azomethine group, and 
other hetero atoms like sulphur in the structure, Schiff 
bases together with their complexes are reported to 
exhibit significant bioactivity8. 
Proteins are the most profuse macromolecules in 
cells and are crucial in maintaining normal cell 
functions. Bovine serum albumin (BSA), being the 
major component in blood plasma, plays a significant 
role in the transport as well as metabolism of various 
endogenous and exogenous compounds. Since the 
serum albumin is found to be non-antigenic and 
biodegradable, and also readily available, the albumin 
is used as a biomaterial, in drug delivery and as novel 
hydrophilic carrier material. Recently, their conjugation 
with Schiff base is proved to improve their bioactivity 
effectively9. Binding of the Schiff base metal complexes 
with this carrier protein opens the gateway for drug-
protein binding which is found to greatly influence its 
absorption, transport and metabolism properties of 
usual drugs in vertebrates. 
Cancer has been deliberated to be one of the most 
fatal diseases in this present era. Recently, 
investigations on the cytotoxicity of Schiff bases 




along with their complexes are increasing 
exponentially. Observations point to the fact that, the 
anticancer property of Schiff bases is significantly 
increased by coordination to metal ions10-14. Chelation 
theory can explain this enhanced bioactivity accounted 
lipophilic and penetration ability of complexes  
into the lipid membrane15. In rare cases, the ligands 
were found to show higher bioactivity than their 
complexes16. Drugs which are used in the cancer 
treatment follow different mechanism17. However, the 
results are not very encouraging, because they harm 
the healthy cells also. Hence, it is imperative to 
discover new anticancer agents with safe and 
enhanced activity to fight this dreaded disease.  
As mentioned earlier, Schiff base complexes have 
been extensively studied for various applications.  
In recent years, we have studied the catalytic 
applications of some Schiff base complexes18-20. We 
have also established that the electron beam irradiation 
significantly enhances the catalytic efficacy of Schiff 
base complexes21,22. The interesting electrochemical 
properties of Schiff base complexes have been reported 
by us23. The Schiff base complexes have been found to 
be very good antimicrobials24-26. We have confirmed the 
excellent DNA/BSA binding abilities of various Schiff 
base complexes27-29. The Schiff base complexes also 
exhibit good chemical nuclease activity25,26.  
From intense literature survey, and with the 
background of our previous publications, we thought the 
sulphur donor Schiff base complexes can reveal very 
good biological applications. Hence, in this work, we 
have synthesized, characterized and investigated the 
bioactivity of a novel SNSN donor Schiff base, derived 
from thiophene-2-carbaldehyde and pyridine substituted 
thiosemicarbazide, and its complexes with Co(II), Ni(II), 
Cu(II) and Zn(II) metal ions.  
 
Materials and Methods 
Thiophene-2-carboxaldehyde and 4-(pyridin-2-yl)-
thiosemicarbazide were purchased in pure form,  
from Sigma Aldrich and were used as such. The  
metal salts used in the present study, cobalt(II) 
chloridehexahydrate, nickel(II) chloride hexahydrate, 
copper(II) chloride dihydrate and zinc(II) chloride 
were obtained from Loba Chemie. Tris-buffer was 
obtained from HIMEDIA and BSA was procured 
from Aldrich. 
 
Synthesis of ligand and its complexes 
Equimolar quantities of thiophene-2-carbaldehyde 
and4-(pyridin-2-yl)-thiosemicarbazide were mixed 
thoroughly with minimum quatity of ethanol (5 mL) 
in a clean dry beaker. It was then heated in a 
microwave oven at 100 W power for 10 min. The 
yellow colour Schiff base (L) formed was repeatedly 
washed with ether and dried in vacuo. Equimolar 
mixture of the ligand (L) and the corresponding metal 
salts were mixed with 3 mL of methanol and reacted 
in a microwave oven for 10 min. The synthesis of 
Co(II) complex was carried out in nitrogen 
atmosphere. The newly formed Co(II), Ni(II), Cu(II) 
and Zn(II) complexes of the Schiff base L were 
washed repeatedly with water and dried. Schematic 
representation of the Schiff Base ligand and its 
complexes are shown in Scheme 1. 
 
Characterisation techniques 
The 1H and 13C NMR spectrum of Schiff base L 
was recorded on a JEOL GSX-400 spectrometer 
taking CDCl3 as solvent at normal room temperature. 
The mass spectrum (EI) was detected using JEOL  
D-300 mass spectrometer. The infrared spectra of all 
the samples were obtained using JASCO/FT-IR 410 
spectrometer in the wavenumber range of 4000-400 cm-1. 
Electronic spectra in the range of 200-800 nm were 
recorded using Perkin Elmer Lambda-35  
UV-visible spectrophotometer using DMSO as 
 
Scheme 1 ― Schematic representation of the Schiff Base ligand
and its complexes 




solvent. The molar conductivities of the complexes 
were obtained in ~10-3 M DMSO solution using a 
coronation digital conductivity meter. Magnetic 
susceptibility measurements were obtained on Hertz 
SG8‐5HJ model Gouy magnetic balance using 
CuSO4.5H2O as the calibrant. The emission spectra 
were detected on a Perkin Elmer LS-45 fluorescence 
spectrophotometer. TG/DTG analyses of the 
complexes were obtained from SIINT 6300, under a 
dynamic N2 atmosphere in the 20–800 °C temperature 
range at a heating rate of 10 °C min-1. Powder XRD 
determinations of the compounds were made using an 
X-ray diffractometer (XPERT PRO PANalytical, 
Netherland). The patterns were run with Cu Kα 
radiation (λ = 0.1545 nm) with a generator at 40 kV 
and 40 mA at 25 °C temperature. The diffracting angle 
(2h) range for XRD spectroscopy from 10° to 80° was 
attained with a rate of 2° min-1. 
 
Antibacterial studies 
Antimicrobial activities of the ligand along with its 
complexes were studied against three bacterial strains 
i.e., Escherichia coli, Klebsiella pneumonia and 
Salmonella typhi using agar well diffusion method by 
sterilizing the Mueller Hinton agar media. After 
solidification, the wells on the Mueller Hinton agar 
were cut bya cork borer. The bacterial pathogens to be 
tested were wiped on the surface of Mueller Hinton 
agar plates. The cut pieces of thin film of samples 
were placed on the well. All the plates were incubated 
at 37 oC for 24 h, and then the zone of inhibition 
formed was measured in millimeters.  
 
BSA binding studies 
The interaction of all the metal complexes with 
Bovine serum albumin (BSA) were studied in a buffer 
medium of 5 mM Tris-HCl/50 mM NaCl maintained at 
a pH of 7.5. The fluorescence spectral titrations were 
conducted at varied concentration of the complexes 
while keeping the BSA concentration as constant. The 
emission spectra of the system were recorded between 
the wavelength range of 250–450 nm upon excitation 
at 280 nm30. The absorption spectra for a fixed 
concentration of both BSA and metal complexes were 




Culturing of cells 
HT29 cells were bought from the National Centre 
for Cell Sciences (NCCS), Pune, India, and were 
grown in a solution of minimum essential medium 
(MEM) containing 10% of 100 IU/mL FBS, penicillin 
100 mg/mL and streptomycin 20 mg/mL. The cells 
were preserved as single layers in 25 cm2 plastic tissue 
culture flasks maintaining the temperature at 310 K at 
humid conditions bearing 5% CO2. The cells were 
reported to be multiplied in the culture, which were 
used all through theexperiments. 
 
MTT assay 
MTT assay was performed to probe the anticancer 
activity of L, [CoL]Cl, [NiL]Cl, [CuL]Cl and [ZnL]Cl 
on HT29 cancer cells. 200 µL of suspension of HT29 
cells (1x105 cell/mL) was added to each well of  
96 well micro titer plates and subjected to incubation 
for 24 h. When the incubation period is over, varying 
concentrations of the samples (10, 20, 30, 40 and  
50 μg/mL) were added to the cells. 20 µL of MTT dye 
was added to each well after 24 h time of incubation. 
The media containing MTT dye solution was removed 
after 4 h. To each well, 200 µL of DMSO was  
added to dissolve the formazan crystals formed. The 
absorbance was measured at 570 nm, by a microplate 
reader spectrophotometer. This measurement was 
repeated three times (in triplicate) in three different 
days. Percentage cell toxicity values were calculated 
using the following equation, 
 
Cell viability (%) = 
 
 
100  ...(1) 
 
Results and Discussion 
 
NMR spectral studies 
In the 1H NMR spectrum of the ligand L (Fig. 1a) 
the singlet appearing at 2.51 ppm corresponds to 
thioenol hydrogen of thiosemicarbazide moiety. The 
peak at 3.41 ppm is due to C-NH proton. The singlet 
appears at 7.56 ppm corresponds to the most 
important azomethine group. The signals in the range 
of 7.1-8.2 ppm arise as a result of aromatic protons of 
the ligand. The 13C NMR spectrum of the ligand L 
(Fig. 1b) shows signals at δ 109.77, 114.97, 140.68 
and 147.99 and 159.11 corresponds to aromatic 
carbons of thiosemicarbazide moiety. The signal at δ 
126.12 corresponds to the azomethine carbon. The 
signal at δ 126.70, 127.85 and 146.93 corresponds to 
aromatic carbons of thiophene moiety. The signal 
obtained at δ183.42 corresponds to –C=S carbon. The 
1H NMR spectrum of [ZnL]Cl is provided in Fig. 1c. 
The NMR spectrum of the Zn(II) complex is very 
similar to that of the L, but for few changes. The 
signal due to thioenol proton, at δ 2.51, has 
disappeared. This confirms the coordination of the 
thioenolic sulphur with Zn(II) through covalent bond. 




The intensity of the signal due to imino proton, at  
~ 7.54, has been considerably reduced, because of the 
coordination of imino nitrogen to Zn(II), which in 
turn reduces the electron density of the proton 
significantly. The changes in the positions and 
intensities of all other protons are insignificant. 
EI Mass spectrum 
The EI mass spectrum of the ligand (Fig. 2) shows 
the molecular ion (M+) peak at m/z = 262.12 
corresponding to the molecular weight of the ligand. 
The peaks at m/z = 182.12, 154.21, 126.16, 98.12, 
74.12 and 64.53 corresponds to various fragments 
C7H7N4S, C6H5N3S, C5H4N2S, C5H4S,C4H3S and 
C4H4N, respectively, which in turn concurs with the 
proposed structure the Schiff base. 
 
FTIR spectra 
The FTIR spectrum of the L (Fig. 3a) exhibits a 
band at 1674 cm-1, due to the imino (CH=N) 
stretching confirming the Schiff base formation31. The 
C-N stretching of pyridine is observed at 1479 cm-1. 
The C-S stretching of thiophene is found at 1173 cm-1 
and the C-S stretching of thioenol appears at 1143 cm-1. 
The FTIR spectra clearly confirm the formation of the 
Schiff base L, with the expected structure. It also 
suggests that the thiocarbonyl group may be partly 
present in its enolic form.  
In the FTIR spectra of the complexes (Fig. 3(b-e)), 
the band corresponding to the azomethine group in L 
(1674 cm-1) is shifted towards lower wavenumber 
region28 which approves the coordination of the imino 
nitrogen atom to the corresponding metal ion forming 
stable complexes (Table 1). Similarly, in the complexes, 
the band for pyridine C-N stretching have been 
shifted to lower wavenumber which is also the  
case for thiophenyl C-S stretching and thioenol C-S 
frequency, confirming the effective coordination of 
ligand L to metal ions. The new bands arising in the 
region of 550 cm-1 is ascribed to the formation of M-
N bonds32,33. The vibrational spectra of the complexes 
show that the ligand L is coordinated to the metal ions 
through imino and pyridine nitrogen atoms. 
 
Electronic spectra, molar conductance and magnetic 
measurements 
The electronic spectra of the complexes are 
provided in Fig. 4. In all the complexes, the high 
intense peak around 300 nm corresponds to π-π* 
transition34. The electronic spectrum of [CoL]Cl has 
only one d-d band in the visible region at 520 nm,  
due to 4A2(F) → 
4T1(P) transition indicating sp
3 
hybridized tetrahedral geometry. The d-d band for 
[NiL]Cl is observed at 510 nm, which is due to the 
3T1(F) → 
3T1(P) transition demonstrating tetrahedral 
geometry, with sp3 hybridization. The spectrum of 
[CuL]Cl exhibits two less intense d-d bands centered 
at 525 nm and 700 nm due to 2B1g → 
2Eg and 
2B1g → 
2B2g  transitions   corresponding   to   dsp
2   hybridized  
 
 
Fig. 1 ― (a) 1H, (b) 13C NMR spectrum of Schiff base ligand L
and (c) 1H NMR spectrum of complex [ZnL]Cl 
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agrees to the square planar geometry of the complex. 
The spectrum shows four lines due to hyperfine 
splitting having a nuclear spin value of 3/2. i.e.,  
four low intense well resolved peaks at low-field 
region and one intense peak in high-field region as a 
result of coupling of the unpaired electron with the 
nuclear spin of Cu(II)41. The g|| and g⊥ values are 
found to be 2.242 and 2.158, respectively, which 
follows the trend of g||> g⊥>2.0023 showing that the 
unpaired electron is in the dx
2
-y
2 orbital having 2B1g as 
the ground state42.  
 
Thermal studies 
TG/DTG measurements of the complexes were 
studied in the temperature range of 25-800 oC (Fig. 6, 
S1-S3, Supplementary Data). The thermograms  
of the complexes show weight loss upto 100 oC, 
accompanied by the removal of lattice water molecules 
and chloride ions present outside the coordination 
sphere of the complexes. In [CoL]Cl, decomposition 
at 370 oC corresponding to a weight loss of 20% is 
due to the partial decomposition of coordinated 
ligand. The next step of the thermal degradation that 
occurs between 530–650 oC (~36% weight loss) 
corresponds to the removal of remaining organic 
ligand moiety leaving the metal oxide residue. 
However, in [NiL]Cl weight loss at 350 oC is due to 
partial decomposition of ligand and a major degradation 
at 450-550 oC is due to complete decomposition of 
organic ligand moiety leaving behind the metal oxide 
residue. Thermal decomposition curve of [CuL]Cl 
shows weight loss of 80% at 350 oC corresponding to 
the decomposition of major part of the coordinated 
ligand. The next step of the thermal degradation  
that occurs between 450 oC (~10% weight loss) 
corresponds to the removal of remaining organic 
ligand moiety leaving the metal oxide residue. In 
[ZnL]Cl, thermal decomposition occurring at 300 oC 
corresponding to a weight loss of 32% is due to the 
partial decomposition of coordinated ligand. The next 
step of the thermal degradation occurring between 
520–680 oC (~40% weight loss) corresponds to the 
removal of remaining organic ligand moiety leaving 
the metal oxide residue. 
 
Powder X-ray diffraction 
The XRD data of [CoL]Cl complex (Fig. 7) is 
recorded at room temperature in the range of 0-80°. 
Several peaks with high intensities were detected 
from XRD. These peaks can be listed as follows; 
20.45, 25.92, 28.11, 33.64, 37.53, 56.84. The highest 
intensity was found at the peak of 20.45°. XRD 
measurement confirmed that this complex is a 
cystalline solid. The average grain size values of the 
[CoL]Cl complex was obtained from Debye-Scherrer 
equation and is found to be 54 nm. 
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bathochromic shift (Fig 9b, S8-S10) confirming the 
static mode of quenching mechanism49. 
 
Analysis of binding constants and binding sites 
The extent of binding of metal complexes with 
BSA is obtained by calculating the binding constants 
(Kb) and the number of binding sites (n) using the 
following equation50, 
log  log K  nlog Q              … (3) 
 
Where, Kb and n values (Table 4) are the intercepts 
and slopes obtained from the linear fits on plotting log 
F0-F/F vs log [Q] at 298 K (Fig. 9c, S11-S13) for the 
metal complexes, respectively. The binding site 
values are approximated to 1 revealing the presence 
of only one binding site in BSA where the complexes 
could bind. Among the two tryptophan residues in 
present in BSA molecule i.e., Trp-134 in sub-domain 
IA and Trp-212 in hydrophobic sub-domain IIA, the 
binding of drug molecules to sub-domain IIA result in 
conformational changes51. This shows that the complexes 
could bind with Trp-212 in sub-domain IIA. 
 
Anticancer activities 
MTT assay on HT29 cell lines was performed in 
order to find the relative cell viability after treating 
with different concentrations of the metal complexes. 
This studies show the maximum concentration at 
which the cell mortality is higher for cancer cell lines 
under study. The cytotoxic effects induced by metal 
complexes at different concentrations (10, 20, 30, 40, 
50 μg/mL) in HT29 cells is shown in Fig. 10. It has 
been observed that the percentage cell toxicity 
increases with increase in metal ions concentration 
and it was found to be maximum at the concentration 
of 50 μg/mL (Table 5). It has been observed that 
[CuL]Cl complex exhibits higher anticancer activity 
than the ligandas well as other synthesised metal 
complexes. The higher cytotoxicity of [CuL]Cl can be 
well explained by its higher BSA binding ability. 
 
Comparison of biological activity  
Recently Jeslin and coworkers52 have studied the 
biological activities of Ni(II), Cu(II) and Zn(II) 
 
 
Fig. 9 ― (a) Emission spectra of BSA in the presence of various
concentrations of [CoL]Cl complex in DMSO (T=298K),
c(BSA)=2.0  10-6 mol L-1, c[CoL]Cl = 2, 4, 6, 8, 10  10-6 mol L-1.
Inset: Stern-Volmer plot for quenching of BSA by [CoL]Cl
complex, (b) UV-visible absorption spectra of BSA and BSA-CoL
solutions: c(BSA) = c[CoL]Cl = 2  10-6 mol L-1 and (c) Double
logarithm plot for BSA-[CoL]Cl 
 
Table 3 ― Ksv and Kq values of the complexes 
Complexes Ksv( 10
4 L mol-1) Kq( 10
12 L mol-1 s-1) 
[CoL]Cl 4.18 4.18 
[NiL]Cl 4.25 4.25 
[CuL]Cl 4.35 4.35 
[ZnL]Cl 4.29 4.29 
 
Table 4 ― Binding constant (Kb) and Binding site (n) values 
of the complexes 
Complexes Binding constant  




[CoL]Cl 5.36 1.07 
[NiL]Cl 5.48 1.02 
[CuL]Cl 5.86 1.11 
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